All Posts: mind
-
Mindfulness-Based Stress Reduction is as Effective as an Antidepressant Drug for Treating Anxiety Disorders
A guided mindfulness-based stress reduction program was as effective as use of the gold-standard drug — the common antidepressant escitalopram — for patients with anxiety disorders, according to results of a first-of-its-kind, randomized clinical trial led by researchers at Georgetown University Medical Center.
Category: News Release
-
Taking Neuroscience to School: Brain Scans Reveal the Hidden Shape of Thinking and Predict Students’ Learning Better Than Test Scores
Category: News Release
-
Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease
WASHINGTON (Friday, November 12, 2021) — In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson’s disease. The finding could help explain an earlier outcome of the same study, in which the drug nilotinib was able to halt motor and […]
Category: News Release
-
Insights Into How a Stroke Affects Reading Could Help With Rehabilitation
WASHINGTON (August 29, 2021) — Georgetown University researchers, looking at the ability of people to sound out words after a stroke, found that knowing which region of the brain was impacted by the stroke could have important implications for helping target rehabilitation efforts. The finding appeared August 30, 2021, in Brain Communications. “One in five […]
Category: News Release
-
Key Mental Abilities Can Actually Improve During Aging
WASHINGTON (August 19, 2021) — It’s long been believed that advancing age leads to broad declines in our mental abilities. Now, new research from Georgetown University Medical Center offers surprisingly good news by countering this view. The findings, published August 19, 2021, in Nature Human Behavior, show that two key brain functions, which allow us […]
Category: News Release
-
Ostroumov Receives Whitehall Grant for Research on Neuropsychiatric Disorders
(March 12, 2021) — Since joining Georgetown’s Department of Pharmacology & Physiology in January 2020, assistant professor Alexey Ostroumov, PhD, has focused on establishing his lab — an especially unique challenge in the midst of a pandemic. “I was lucky to have a great team during the last year that helped me to build the […]
Category: GUMC Stories
-
Study of Reaching and Grasping with Hand or Foot Reveals Novel Brain Insights
WASHINGTON (October 26, 2020) — People born without upper limbs who use their feet to reach for an item engage the same area in the brain that people with hands use to reach for something, report Georgetown University Medical Center neuroscientists. The finding, published October 26, 2020, in PNAS, advances the basic science of brain […]
Category: News Release
-
Study Suggests Unconscious Learning Underlies Belief in God
WASHINGTON (September 9, 2020) — Individuals who can unconsciously predict complex patterns, an ability called implicit pattern learning, are likely to hold stronger beliefs that there is a god who creates patterns of events in the universe, according to neuroscientists at Georgetown University. Their research, reported in the journal Nature Communications, is the first to […]
Category: News Release
-
Early-life Education Improves Memory in Old Age — Especially for Women
WASHINGTON (June 5, 2020) — Education appears to protect older adults, especially women, against memory loss, according to a study by investigators at Georgetown University Medical Center, published in the journal Aging, Neuropsychology, and Cognition. The results suggest that children — especially girls — who attend school for longer will have better memory abilities in […]
Category: News Release
-
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
WASHINGTON (May 29, 2020) — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results […]
Category: News Release